Using indirect comparisons in pharmacoeconomic studies-Time for implementation

Clinical Therapeutics

Volumn 29, Issue 11, 2007, Pages 2454-2455

  Malone, Daniel C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; WARFARIN;

BAYES THEOREM; DECISION MAKING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HEALTH CARE; HEALTH CARE PERSONNEL; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PHARMACOECONOMICS; RISK; STANDARD; TOTAL HIP PROSTHESIS;

ANTICOAGULANTS; ECONOMICS, PHARMACEUTICAL; ENOXAPARIN; HUMANS; RESEARCH DESIGN; WARFARIN;

EID: 37349059264     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.11.011     Document Type: Editorial

References (13)

1. Ramsey S., Willke R., Briggs A., et al. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value Health 8 (2005) 521-533
2. Caldwell D., Ades A., and Higgins J. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ 331 (2005) 897-900
3. Song F., Altman D., Glenny A., and Deeks J. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ 326 (2003) 472
4. Lu G., and Ades A. Combination of direct and indirect evidence in mixed treatment comparisons. Star Med 23 (2004) 3105-3124
5. Nixon R., Bansback N., and Brennan A. Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med. 26 (2007) 1237-1 254
6. O'Brien B., Anderson D., and Goeree R. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. CMAJ 150 (1994) 1083-1090
7. Stettler C., Allemann S., Egger M., et al. Efficacy of drug eluting stents in patients with and without diabetes mellitus: Indirect comparison of controlled trials. Heart 92 (2006) 650-657
8. Moore R., and Derry S. Indirect comparison of interventions using published randomised trials: Systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urol 5 (2005) 18
9. Coomarasamy A., Knox E., Gee H., et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: A meta-analysis with an indirect comparison of randomised trials. BJOG 110 (2003) 1045-1049
10. Bucher H., Guyatt G., Griffith L., and Walter S. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50 (1997) 683-691
11. Ades A., Sculpher M., Sutton A., et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 24 (2006) 1-19
12. Collins R., Fenwick E., Trowman R., et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technol Assess 11 (2007) 1-179 ill-iv, xv-xviii
13. Bucher H., Griffith L., Guyatt G., and Opravil M. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. J Acquir Immune Defic SyndrHum Retrovirol 15 (1997) 104-114